ViaDerma, Inc. engages with the manufacturing and sales of pharmaceutical related products. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2008-06-10. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The firm also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a patent pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The firm utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Follow-Up Questions
Viaderma Inc (VDRM)'in P/E oranı nedir?
Viaderma Inc 'in P/E oranı 0.0924 'dir
Viaderma Inc 'in CEO'su kimdir?
Rui Sheng Liu 2009 'den beri şirketle birlikte olan Viaderma Inc 'in President 'ıdır.
VDRM hissesinin fiyat performansı nasıl?
VDRM 'in mevcut fiyatı $0.0002 'dir, son işlem günde 0% decreased etti.
Viaderma Inc için ana iş temaları veya sektörler nelerdir?
Viaderma Inc Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Viaderma Inc 'in piyasa değerlemesi nedir?
Viaderma Inc 'in mevcut piyasa değerlemesi $246.7K 'dir
